Sound wave weapon joins fight against deadly pancreatic cancer
NCT ID NCT07325214
Summary
This study is testing whether adding a focused ultrasound treatment (called IMD10) to standard chemotherapy helps people with borderline or locally advanced pancreatic cancer live longer. About 136 participants will be randomly assigned to receive either chemotherapy alone or chemotherapy plus the ultrasound treatment. The main goal is to see if the combination improves overall survival for this hard-to-treat cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Contact
-
Seoul National University Bundang Hospital,
Gyeonggi-do, 13620, South Korea
Contact
-
Seoul National University Hospital
Seoul, 03080, South Korea
Contact
-
University of Texas Health Science Center at San Antonio
San Antonio, Texas, 78229, United States
Contact
-
University of Virginia Medical Center
Charlottesville, Virginia, 22908, United States
Contact
Conditions
Explore the condition pages connected to this study.